Suppr超能文献

与血液透析相关的血清甲状腺激素浓度的周期性变化:激素进出血管外间隙的移动可能是一种机制。

Cyclical changes in serum thyroid hormone concentrations related to hemodialysis: movement of hormone into and out of the extravascular space as a possible mechanism.

作者信息

van Leusen R, Meinders A E

出版信息

Clin Nephrol. 1982 Oct;18(4):193-9.

PMID:7140033
Abstract

Chronic hemodialysis (CHD) patients suffer from a chronic illness that is believed not to involve the thyroid. However, they may have low serum T4 and T3 concentrations. The influence of a single hemodialysis treatment on serum thyroid hormone concentrations was studied in twenty-three CHD patients. It was found that serum total T4 and free T4 concentrations were significantly higher immediately after hemodialysis than before treatment. Immediately after hemodialysis serum T3 and TSH concentrations were unchanged. Eighteen hours after hemodialysis the serum total T4 and free T4 levels were still elevated, but, at this time, serum T3 levels were also higher than before dialysis. The serum TSH levels remain unchanged. Seventy-two hours after the start of the hemodialysis treatment, all thyroid hormone concentrations had returned to their original predialysis levels. Correction for hemoconcentration or dilution did not influence these results. We could not demonstrate any correlation between the changes in serum urea-N and creatinine levels and the observed changes in serum thyroid hormone concentrations. These cyclical changes in serum thyroid hormone levels may be ascribed to the combined effects of heparin administration during hemodialysis and the accumulation and removal of uremic substances, both of which are capable of competitive binding of thyroid hormone binding sites. For practical purposes it is important to specify the time of blood sampling in relation to a hemodialysis treatment when studying serum thyroid hormone levels in CHD patients.

摘要

慢性血液透析(CHD)患者患有被认为与甲状腺无关的慢性疾病。然而,他们的血清T4和T3浓度可能较低。在23例CHD患者中研究了单次血液透析治疗对血清甲状腺激素浓度的影响。发现血液透析后即刻血清总T4和游离T4浓度显著高于治疗前。血液透析后即刻血清T3和TSH浓度未改变。血液透析18小时后血清总T4和游离T4水平仍升高,但此时血清T3水平也高于透析前。血清TSH水平保持不变。血液透析治疗开始72小时后,所有甲状腺激素浓度均恢复至透析前的原始水平。校正血液浓缩或稀释不影响这些结果。我们未能证明血清尿素氮和肌酐水平的变化与观察到的血清甲状腺激素浓度变化之间存在任何相关性。血清甲状腺激素水平的这些周期性变化可能归因于血液透析期间肝素给药以及尿毒症物质的蓄积和清除的联合作用,这两者都能够竞争性结合甲状腺激素结合位点。出于实际目的,在研究CHD患者的血清甲状腺激素水平时,明确采血时间与血液透析治疗的关系很重要。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验